By expenditures
| Name | Title | Type |
|---|---|---|
| Charles Hicklin | Chief Financial Officer And Controller | Auditee |
| Amanda Blomberg | Managing Director | Auditee |
| Charles Hicklin | Chief Financial Officer and Controller | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 366786 | 2024 | 2025-09-19 | Baker Tilly US LLP | $81.32M |
| 320246 | 2023 | 2024-09-20 | Baker Tilly US LLP | $103.11M |
| 51738 | 2022 | 2023-09-18 | Baker Tilly US LLP | $132.26M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 320246 | 2023 | 2024-09-20 | 1073906 | 2023-002 | Significant Deficiency | Yes | CL |
| 320246 | 2023 | 2024-09-20 | 1073905 | 2023-002 | Significant Deficiency | Yes | CL |
| 320246 | 2023 | 2024-09-20 | 1073904 | 2023-002 | Significant Deficiency | Yes | CL |
| 320246 | 2023 | 2024-09-20 | 1073903 | 2023-004 | Significant Deficiency | - | L |
| 320246 | 2023 | 2024-09-20 | 1073902 | 2023-003 | Significant Deficiency | - | M |
| 320246 | 2023 | 2024-09-20 | 497464 | 2023-002 | Significant Deficiency | Yes | CL |
| 320246 | 2023 | 2024-09-20 | 497463 | 2023-002 | Significant Deficiency | Yes | CL |
| 320246 | 2023 | 2024-09-20 | 497462 | 2023-002 | Significant Deficiency | Yes | CL |
| 320246 | 2023 | 2024-09-20 | 497461 | 2023-004 | Significant Deficiency | - | L |
| 320246 | 2023 | 2024-09-20 | 497460 | 2023-003 | Significant Deficiency | - | M |
| 51738 | 2022 | 2023-09-18 | 620369 | 2022-005 | Significant Deficiency | - | AB |
| 51738 | 2022 | 2023-09-18 | 620368 | 2022-002 | Significant Deficiency | - | CL |
| 51738 | 2022 | 2023-09-18 | 43927 | 2022-005 | Significant Deficiency | - | AB |
| 51738 | 2022 | 2023-09-18 | 43926 | 2022-002 | Significant Deficiency | - | CL |